Product Information
CROMOLYN 100 MG/5 ML ORAL CONC is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3306 per ML under NDC 51525047009. Its NADAC has been published 507 times since Feb 10, 2016.
FDA first approved this application on Feb 29, 1996. Its Orange Book therapeutic-equivalence code is AA.
Strength
100 mg/5mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
51525047009
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
CROMOLYN SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA020479FDA Approved
2/29/1996
TE Code
AA
On Market Since
10/21/2015
Pharmacological Classes
Price Statistics
The NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has been published 507 times since Feb 10, 2016, and over the history we have for it it has declined 64.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3306 per ML |
|---|---|
| All-time high | $0.9558 (Sep 14, 2016) |
| All-time low | $0.1665 (Nov 20, 2024) |
| 52-week high | $0.3364 |
| 52-week low | $0.3299 |
| Median price | $0.4314 |
| Average price | $0.4995 |
| Largest weekly change | +85.7% (Jan 17, 2024) |
| Weeks tracked | 507 |
| Tracking since | Feb 10, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
+0.2%
1Y
+22.7%
3Y
+20.4%
5Y
-20.0%
All
-64.5%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the cromolyn sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cromolyn sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Mast Cell Stabilizer class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CROMOLYN 100 MG/5 ML ORAL CONC?
The current National Average Drug Acquisition Cost (NADAC) for CROMOLYN 100 MG/5 ML ORAL CONC, manufactured by Mylan Pharmaceuticals Inc., is $0.3306 per ML (NDC 51525047009), effective Jul 1, 2026.
How has the price of CROMOLYN 100 MG/5 ML ORAL CONC changed over time?
Over the history we have for it, the NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has declined 64.5%. It has been tracked across 507 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for CROMOLYN 100 MG/5 ML ORAL CONC?
Since Feb 10, 2016, the NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has ranged from a low of $0.1665 (Nov 20, 2024) to a high of $0.9558 (Sep 14, 2016), with a median of $0.4314 per ML.
Are there cheaper alternatives to CROMOLYN 100 MG/5 ML ORAL CONC?
No other NADAC-published product currently shares the active ingredient and strength of CROMOLYN 100 MG/5 ML ORAL CONC in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CROMOLYN 100 MG/5 ML ORAL CONC?
CROMOLYN 100 MG/5 ML ORAL CONC (NDC 51525047009) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.